MYOVANT SCIENCES news, videos and press releases
For more news please use our advanced search feature.
MYOVANT SCIENCES - More news...
MYOVANT SCIENCES - More news...
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
- Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
- MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
- MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
- MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences
- Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
- Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
- Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022
- MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
- SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Myovant Sciences Ltd. - MYOV
- SHAREHOLDER ALERT: Weiss Law Investigates Myovant Sciences Ltd.
- Myovant Sciences Cancels Second Quarter Earnings Conference Call
- Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic?
- MYOV STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Myovant Sciences Ltd. Is Fair to Shareholders
- Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
- Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
- Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
- CORRECTION -- Myovant Sciences, Inc.
- Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.
- Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
- Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
- Myovant Recognizes Prostate Cancer Awareness Month with Educational Sponsorships and Online Campaign to Encourage Patients to Speak Up, Seek Support and Be Informed
- Myovant Sciences to Participate at Upcoming Investor Conferences
- Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
- Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
